New York [US]/ London [UK]/ Munich [Germany]/ New Delhi [India], February 11: Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as Strategic Advisor, reinforcing its commitment to advancing early cancer detection and precisio
New Delhi [India] / London [UK] / Munich [Germany], January 28: Datar Cancer Genetics (DCG) has launched a revolutionary video-reporting service for in-vitro chemosensitivity testing, powered by AI-driven technology. This innovation provides oncologists with real-time visual evidence of chem
Certain anti-cancer medications also target healthy cells in addition to malignant cells. Their use may become restricted if their effects on the latter are excessively powerful. The mechanism of action of PARP inhibitors, which are specifically used for treating breast and ovarian cancer in
Lung cancer is not the most frequent type of cancer, but it is by far the most deadly. Despite therapies such as surgery, radiation therapy, and chemotherapy, only about a quarter of all persons with the disease will live more than five years following diagnosis, and the World Health Organiz
Lung adenocarcinoma is the most common type of lung cancer, accounting for the majority of cancer-related fatalities in the US. There are various causes of lung adenocarcinoma, one of which is a mutation in a protein known as EGFR. Non-mutant EGFR stimulates cell proliferation in response to
Water cycling across membrane transporters is a characteristic of cell metabolism and has the potential to be very diagnostic in the characterisation of tumours and other illnesses.
The potential of artificial DNA constructs that, when used in conjunction with antibodies, tell the immune system to focus on malignant cells in particular is highlighted by a recent study.
Glioblastoma, the most prevalent and lethal type of brain cancer, spreads quickly, invading and destroying healthy brain tissue. The tumour shoots malignant tendrils into the brain, making surgical removal of the tumour extremely difficult or impossible.
Boston [US]/Bangalore (Karnataka) [India], August 11: Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today announces that the US Food and Drug Administration (FDA) has granted the company's In
According to a new study, melanoma skin cancer cells fundamentally reorganise their internal power systems in order to move to other places of the body.